Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Polly A. Murphy files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- BAKER BROS. ADVISORS LP - $317.75M in CELC purchases and sales in the last 12 months
- David Dalvey - $7.42M in CELC purchases and sales in the last 12 months
- Richard E. Buller - $2.08M in CELC purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Polly A. Murphy?
Polly A. Murphy is a corporate insider of Atea Pharmaceuticals, Inc. (AVIR). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Polly A. Murphy last file a Form 4?
The most recent primary Form 4 on record is dated 23 June 2026, one of 5 filings going back to 2026.
Has Polly A. Murphy been buying or selling stock?
Recorded transactions: 2 open-market purchases ($51K) and 0 open-market sales across all tracked filings.
